Qiagen NV QGEN
News
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer
QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery
QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel
QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation
QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction
QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
Qiagen Wins FDA Clearance for Bloodstream Infection Test
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook

